{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:39:13Z","timestamp":1791473953118,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070192"],"award-info":[{"award-number":["82070192"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670171"],"award-info":[{"award-number":["81670171"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Tianjin Municipal Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011342","name":"State Key Laboratory of Experimental Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jtct.2022.06.007","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T13:29:28Z","timestamp":1655213368000},"page":"589.e1-589.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Higher Dose of CD34+ cells Promotes Early Reconstitution of Natural Killer Cells and Is Associated with Better Outcomes After Unmanipulated Hematopoietic Stem Cell Transplantation for Myeloid Malignancies"],"prefix":"10.1016","volume":"28","author":[{"given":"Fei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1125-6939","authenticated-orcid":false,"given":"Yuanyuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiming","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sizhou","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0311-6725","authenticated-orcid":false,"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erlie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1720-6799","authenticated-orcid":false,"given":"Mingzhe","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"436","key":"10.1016\/j.jtct.2022.06.007_bib0001","doi-asserted-by":"crossref","first-page":"eaap9630","DOI":"10.1126\/scitranslmed.aap9630","article-title":"Hematopoietic stem cell transplantation in its 60s: a platform for cellular therapies","volume":"10","author":"Chabannon","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jtct.2022.06.007_bib0002","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/bmt.2015.306","article-title":"Causes of mortality after haploidentical hematopoietic stem cell transplantation and the comparison with HLA-identical sibling hematopoietic stem cell transplantation","volume":"51","author":"Yan","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.06.007_bib0003","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/bmt.2016.283","article-title":"Comparable post-relapse outcomes between haploidentical and matched related donor allogeneic stem cell transplantation","volume":"52","author":"Ma","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.06.007_bib0004","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3389\/fimmu.2016.00507","article-title":"Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation","volume":"7","author":"Ogonek","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2022.06.007_bib0005","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bbmt.2015.01.019","article-title":"Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome","volume":"21","author":"Kim","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.06.007_bib0006","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bbmt.2018.02.023","article-title":"Early Reconstitution of NK and \u03b3\u03b4 T Cells and Its Implication for the Design of Post-Transplant Immunotherapy","volume":"24","author":"de Witte","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.06.007_bib0007","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.3389\/fimmu.2019.02794","article-title":"Innate immune responses in the outcome of haploidentical hematopoietic stem cell transplantation to cure hematologic malignancies","volume":"10","author":"Zaghi","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2022.06.007_bib0008","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2006.06.013","article-title":"Human NK cell education by inhibitory receptors for MHC class I","volume":"25","author":"Anfossi","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jtct.2022.06.007_bib0009","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/sj.leu.2404892","article-title":"Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia","volume":"21","author":"Savani","year":"2007","journal-title":"Leukemia"},{"issue":"5562","key":"10.1016\/j.jtct.2022.06.007_bib0010","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jtct.2022.06.007_bib0011","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood.V94.1.333.413a31_333_339","article-title":"Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation","volume":"94","author":"Ruggeri","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.06.007_bib0012","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3324\/haematol.13033","article-title":"The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease","volume":"93","author":"Dunbar","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2022.06.007_bib0013","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/bmt.2010.306","article-title":"Lymphocyte subset recovery and outcome after T-cell replete allogeneic hematopoietic SCT","volume":"46","author":"B\u00fchlmann","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.06.007_bib0014","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.bbmt.2016.09.006","article-title":"Early natural killer cell reconstitution predicts overall survival in T cell-replete allogeneic hematopoietic stem cell transplantation","volume":"22","author":"Minculescu","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.06.007_bib0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbmt.2007.12.497","article-title":"Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies","volume":"14","author":"Chang","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.06.007_bib0016","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fimmu.2020.02022","article-title":"Influence of KIR and NK cell reconstitution in the outcomes of hematopoietic stem cell transplantation","volume":"11","author":"Gao","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2022.06.007_bib0017","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fimmu.2016.00144","article-title":"Functional reconstitution of natural killer cells in allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Ullah","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2022.06.007_bib0018","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00281-008-0136-1","article-title":"Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation","volume":"30","author":"Velardi","year":"2008","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jtct.2022.06.007_bib0019","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3389\/fimmu.2020.01068","article-title":"Improved relapse-free survival in patients with high natural killer cell doses in grafts and during early immune reconstitution after allogeneic stem cell transplantation","volume":"11","author":"Minculescu","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2022.06.007_bib0020","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1182\/blood-2001-12-0293","article-title":"In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells","volume":"100","author":"Cooper","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.06.007_bib0021","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1074-7613(00)80664-0","article-title":"IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation","volume":"9","author":"Lodolce","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.jtct.2022.06.007_bib0022","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbmt.2008.10.023","article-title":"Donor and recipient CMV serostatus and outcome of pediatric allogeneic HSCT for acute leukemia in the era of CMV-preemptive therapy","volume":"15","author":"Behrendt","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.06.007_bib0023","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1182\/blood-2013-02-487074","article-title":"CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia","volume":"122","author":"Green","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.06.007_bib0024","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1506002","article-title":"Antilymphocyte globulin for prevention of chronic graft-versus-host disease","volume":"374","author":"Kr\u00f6ger","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2022.06.007_bib0025","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1182\/bloodadvances.2016001560","article-title":"ATG in allogeneic stem cell transplantation: standard of care in 2017?","volume":"1","author":"Bacigalupo","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2022.06.007_bib0026","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1038\/s41409-019-0505-5","article-title":"Effect of plasmapheresis on ATG (Thymoglobulin) clearance prior to adoptive T cell transfer","volume":"54","author":"Zhang","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.06.007_bib0027","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.06.007_bib0028","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.06.007_bib0029","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.bbmt.2020.05.022","article-title":"Comparative study of mizoribine and mycophenolate mofetil combined with a calcineurin inhibitor-based immunosuppressive regimen in patients with alternative donor hematopoietic cell transplantation","volume":"26","author":"Huang","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.06.007_bib0030","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1182\/blood-2004-10-4113","article-title":"NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect","volume":"105","author":"Nguyen","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.06.007_bib0031","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1399-3062.2010.00497.x","article-title":"Risk factors and prognosis of invasive fungal infections in allogeneic stem cell transplantation recipients: a single-institution experience","volume":"12","author":"Zhang","year":"2010","journal-title":"Transplant Infect Dis"},{"key":"10.1016\/j.jtct.2022.06.007_bib0032","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1182\/blood-2013-05-499830","article-title":"CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT","volume":"122","author":"Schmidt-Hieber","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.06.007_bib0033","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bbmt.2019.09.028","article-title":"Impact of cytomegalovirus reactivation and natural killer reconstitution on outcomes after allogeneic hematopoietic stem cell transplantation: a single-center analysis","volume":"26","author":"Ando","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.06.007_bib0034","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1182\/blood.V83.9.2594.2594","article-title":"Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of a CD34+7+ NK progenitor","volume":"83","author":"Miller","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.06.007_bib0035","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.cell.2017.02.021","article-title":"Systemic human ILC precursors provide a substrate for tissue ILC differentiation","volume":"168","author":"Lim","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jtct.2022.06.007_bib0036","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4049\/jimmunol.179.1.89","article-title":"CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts","volume":"179","author":"Chan","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2022.06.007_bib0037","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.it.2013.07.005","article-title":"Location and cellular stages of natural killer cell development","volume":"34","author":"Yu","year":"2013","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jtct.2022.06.007_bib0038","article-title":"Transcription factors associated with IL-15 cytokine signaling during NK cell development","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2022.06.007_bib0039","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/s41409-020-0817-5","article-title":"A high CD34 (+) cell dose is associated with better disease-free survival in patients with low-risk diseases undergoing peripheral blood stem cell transplantation from HLA-matched related donors","volume":"55","author":"Yokoyama","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.06.007_bib0040","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2017-05-785659","article-title":"Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation","volume":"130","author":"Ciurea","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.06.007_bib0041","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3109\/14653249.2012.715243","article-title":"Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation","volume":"14","author":"Bosch","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jtct.2022.06.007_bib0042","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3324\/haematol.2009.021121","article-title":"Reconstitution of natural killer cell receptors influences natural killer activity and relapse rate after haploidentical transplantation of T- and B-cell depleted grafts in children","volume":"95","author":"Pfeiffer","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2022.06.007_bib0043","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.leukres.2013.09.005","article-title":"Recovery of natural killer cells and prognosis after cord blood transplantation","volume":"37","author":"Yamamoto","year":"2013","journal-title":"Leukemia Res"},{"key":"10.1016\/j.jtct.2022.06.007_bib0044","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nri.2015.9","article-title":"Natural killer cell memory in infection, inflammation and cancer","volume":"16","author":"Cerwenka","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtct.2022.06.007_bib0045","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.bbmt.2015.07.019","volume":"21","author":"Takenaka","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.06.007_bib0046","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1182\/blood.V98.12.3221","volume":"98","author":"Zaucha","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.06.007_bib0047","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.bbmt.2017.10.043","article-title":"Impact of a low CD34 (+) cell dose on allogeneic peripheral blood stem cell transplantation","volume":"24","author":"Yamamoto","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.06.007_bib0048","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.bbmt.2018.05.007","article-title":"Status of natural killer cell recovery in day 21 bone marrow after allogeneic hematopoietic stem cell transplantation predicts clinical outcome","volume":"24","author":"Hattori","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.06.007_bib0049","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.leu.2405041","article-title":"Involvement of mature donor T cells in the NK cell reconstitution after haploidentical hematopoietic stem-cell transplantation","volume":"22","author":"Nguyen","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2022.06.007_bib0050","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1182\/blood-2005-04-1644","article-title":"KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation","volume":"106","author":"Cooley","year":"2005","journal-title":"Blood"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722013689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722013689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:04:46Z","timestamp":1763003086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636722013689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2666636722013689"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2022.06.007","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher Dose of CD34+ cells Promotes Early Reconstitution of Natural Killer Cells and Is Associated with Better Outcomes After Unmanipulated Hematopoietic Stem Cell Transplantation for Myeloid Malignancies","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2022.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}